Skip to main content

Table 2 Patient’s characteristics

From: Systemic infection and microglia activation: a prospective postmortem study in sepsis patients

 

Control N = 15

Septic shock N = 16

p-value

Female n (%)

7 (46.7)

5 (31.3)

0.473

Age in years. Median (IQR)

70.1 (65.2–87.4)

68.6 (58.9–71.7)

0.119

Living independently. N (%)

13 (86.7)

16 (100.0)

0.226

N of chronic illnesses. Median (IQR)

3 (1–4)

2 (0–3)

0.060

Medical history

 Diabetes. N (%)

4 (26.7)

4 (25.0)

1.00

 Hypertension. N (%)

11 (73.3)

10 (62.5)

0.704

 Heartfailure (NYHA ≥II). N (%)

6 (40.0)

1 (6.3)

0.037

 Cardiac other. N (%)

11 (73.3)

8 (50.0)

0.273

 Peripheral vasculopathy. N (%)

2 (13.3)

0

0.226

 Dyslipidemia. N (%)

6 (40.0)

2 (12.5)

0.113

 CVA. N (%)

3 (20.0)

1 (6.3)

0.333

 Chronic kidney disease (≥G3). N (%)

5 (33.3)

3 (18.8)

0.433

 Livercirrhosis. N (%)

0

1 (6.3)

0.325

 COPD (GOLD≥2). N (%)

0

2 (12.5)

0.333

 Inflammatory disease. N (%)

3 (20.0)

1 (6.3)

0.704

 Malignancy. N (%)

4 (26.7)

6 (37.5)

 

 Immune compromised. N (%)

0

0

 

 Alcohol or drug abuse. N (%)

1 (6.7)

1 (6.3)

1.00

 N regular medication. Median (IQR)

7.5 (5.3–12.5)

6 (2.0–12.0)

0.223

Anticholinergic scores. Median (IQR)

 ACB score.

2.5 (1.0–3.0)

1.0 (0.0–2.8)

0.146

 ARS score.

0 (0–0)

0 (0–0.75)

0.423

  1. ACB anticholinergic cognitive burden list, ARS anticholinergic risk scale, COPD chronic obstructive pulmonary disease, CVA cerebrovascular accident, NYHA New York heart association